Avalon Globocare Corp

詳細情報 Avalon Globocare Corp 企業名

Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering transformative, precision diagnostics and clinical laboratory services. The Company offers diagnostic testing utilizing proprietary technology to deliver genetics-driven results. It operates through two segments: Real property rental and Lab Services MSO. Lab Services MSO segment is focused on delivering services related to toxicology and wellness testing and provides a portfolio of diagnostic tests including drug testing, toxicology, and a range of test services, from general bloodwork to anatomic pathology, and urine toxicology. Its capabilities include STAT blood testing, qualitative drug screening, genetic testing, urinary testing, and sexually transmitted disease testing. The Lab Services MSO segment is also focused on the commercialization of genetic-based proprietary testing. It is also exploring the commercialization and development of a versatile breathalyzer system, KetoAir breathalyzer.

企業情報

企業コードALBT

会社名Avalon Globocare Corp

上場日Feb 22, 2016

最高経営責任者「CEO」Dr. David Jin, M.D., Ph.D.

従業員数5

証券種類Ordinary Share

決算期末Feb 22

本社所在地4400 Route 9

都市FREEHOLD

証券取引所NASDAQ Capital Market Consolidated

国United States of America

郵便番号07728

電話番号17327804400

ウェブサイトhttps://www.avalon-globocare.com/

企業コードALBT

上場日Feb 22, 2016

最高経営責任者「CEO」Dr. David Jin, M.D., Ph.D.

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Wenzhao (Daniel) Lu

Chairman of the Board of Directors

238.93K

--

Dr. David Jin, M.D., Ph.D.

President, Chief Executive Officer, Director

103.00K

--

Ms. Meng Li

Chief Operating Officer, Company Secretary

34.33K

--

Ms. Lourdes Felix

Independent Director

--

Mr. William B. Stilley, III

Independent Director

--

Ms. Luisa Ingargiola

Chief Financial Officer

--

Mr. Wilbert J. (Billy) Tauzin, II

Director

--

Dr. The Hon. Tevi Troy, Ph.D.

Independent Director

--

Mr. Steven Andrew Sanders, J.D.

Independent Director

--

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Wenzhao (Daniel) Lu

Chairman of the Board of Directors

238.93K

--

Dr. David Jin, M.D., Ph.D.

President, Chief Executive Officer, Director

103.00K

--

Ms. Meng Li

Chief Operating Officer, Company Secretary

34.33K

--

Ms. Lourdes Felix

Independent Director

--

Mr. William B. Stilley, III

Independent Director

--

Ms. Luisa Ingargiola

Chief Financial Officer

--

収益内訳

データなし

データなし

事業別

地域別

データなし

株主

更新時刻: Wed, Sep 3

株主統計

種類

株主統計

比率

Lu (Wenzhao)

6.23%

Jin (David)

2.69%

Vision Capital NY, Inc.

2.61%

Li (Meng)

0.90%

Equitable Holdings, Inc.

0.37%

他の

87.21%

株主統計

比率

Lu (Wenzhao)

6.23%

Jin (David)

2.69%

Vision Capital NY, Inc.

2.61%

Li (Meng)

0.90%

Equitable Holdings, Inc.

0.37%

他の

87.21%

種類

株主統計

比率

Individual Investor

9.84%

Corporation

2.61%

Investment Advisor

0.52%

Investment Advisor/Hedge Fund

0.24%

Research Firm

0.03%

他の

86.76%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

37

494.33K

14.25%

+85.10K

2025Q1

39

494.33K

24.18%

+84.18K

2024Q4

39

426.83K

39.01%

+28.37K

2024Q3

38

465.14K

44.22%

+32.28K

2024Q2

37

431.58K

58.50%

+7.86K

2024Q1

35

421.26K

56.90%

-5.41K

2023Q4

36

425.06K

58.60%

-685.00

2023Q3

43

423.55K

58.41%

-5.26K

2023Q2

52

423.10K

61.82%

-6.80K

2023Q1

75

458.47K

67.74%

-1.02K

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

Lu (Wenzhao)

238.93K

11.69%

+9.00

+0.00%

Mar 31, 2025

Jin (David)

103.00K

5.04%

--

Mar 31, 2025

Vision Capital NY, Inc.

100.00K

4.89%

+100.00K

--

Mar 31, 2025

Li (Meng)

34.33K

1.68%

+1.00

+0.00%

Mar 31, 2025

Equitable Holdings, Inc.

14.22K

0.7%

+14.22K

--

Mar 31, 2025

UBS Financial Services, Inc.

2.56K

0.13%

-3.12K

-54.92%

Mar 31, 2025

Tauzin (Wilbert J II)

1.04K

0.05%

+1.04K

--

Mar 31, 2025

詳細を見る

2.690USD

Avalon Globocare Corp

2.690

概要

企業名

金融

分析